Hans M.N. Essers’s research while affiliated with Maastricht University and other places

What is this page?


This page lists works of an author who doesn't have a ResearchGate profile or hasn't added the works to their profile yet. It is automatically generated from public (personal) data to further our legitimate goal of comprehensive and accurate scientific recordkeeping. If you are this author and want this page removed, please let us know.

Publications (2)


Location of the MOX accelerometer on the upper leg.
Flowchart of the data analysis. * In the case of a quadratic relationship, quadratic independent terms were added to the model. Different nested mixed models with and without serial correlation were compared in order to find the most parsimonious model.
Mean self-reported extent of functional limitations of DFNA9 patients with BV and the age-matched control group, measured during six consecutive days. The higher the number on the Likert scale, the higher the experienced functional limitation (1 = not at all; 7 = very much). Dots and squares represent the mean of groups; error bars indicate standard deviation.
Mean of individual mean self-reported extent of tiredness of DFNA9 patients with BV and the age-matched control group, measured during six consecutive days. The higher the number on the Likert scale, the higher the experienced functional limitation (1 = not at all; 7 = very much). Dots and squares represent the mean of groups; error bars indicate standard deviation.
Relative frequency (%) of the type of activities performed during six days for patients with DFNA9 with BV and the age-matched control group.

+7

The DizzyQuest Combined with Accelerometry: Daily Physical Activities and Limitations among Patients with Bilateral Vestibulopathy Due to DFNA9
  • Article
  • Full-text available

February 2024

·

70 Reads

·

2 Citations

·

Sofie de Hoon

·

·

[...]

·

Background: DFNA9 is a genetic disease of the inner ear, causing progressive bilateral sensorineural deafness and bilateral vestibulopathy (BV). In this study, DizzyQuest, a mobile vestibular diary, and the MOX accelerometer were combined to assess the daily life functional limitations and physical activity of patients with DFNA9 suffering from BV. These parameters might be appropriate as potential candidacy criteria and outcome measures for new therapeutic interventions for BV. Methods: Fifteen DFNA9 patients with BV and twelve age-matched healthy controls were included. The DizzyQuest was applied for six consecutive days, which assessed the participants’ extent of functional limitations, tiredness, types of activities performed during the day, and type of activity during which the participant felt most limited. The MOX accelerometer was worn during the same six days of DizzyQuest use, measuring the participants intensity and type of physical activity. Mixed-effects linear and logistic regression analyses were performed to compare the DFNA9 patients and control group. Results: DFNA9 patients with BV felt significantly more limited in activities during the day compared to the age-matched controls, especially in social participation (p < 0.005). However, these reported limitations did not cause adjustment in the types of activities and did not reduce the intensity or type of physical activity measured with accelerometry. In addition, no relationships were found between self-reported functional limitations and physical activity. Conclusions: This study demonstrated that self-reported functional limitations are significantly higher among DFNA9 patients with BV. As a result, these limitations might be considered as part of the candidacy criteria or outcome measures for therapeutic interventions. In addition, the intensity or type of physical activity performed during the day need to be addressed more specifically in future research.

Download

Citations (1)


... Clinical feasibility of combined DVA and gait assessment would be further increased by using more clinically feasible and affordable methods (e.g., wearable sensors or markerless motion capture systems) to assess gait parameters rather than camera-based 3D motion capture systems. While these are gradually being used more to assess physical activity in BVP, 9,27 their accuracy and reliability for assessing gait parameters compared to 3D motion capture has not been assessed in people with BVP. In other populations, this has been extensively researched [28][29][30] and two important considerations have emerged: achieving accurate detection of gait events (i.e., heel strike and toe-off) is critical but challenging 31,32 ; and while assessment of temporal parameters (e.g., step time) can be accurate, 28,33 assessment of spatial parameters (i.e., step length) is challenging. ...

Reference:

Assessing gait variability concurrently with dynamic visual acuity on a treadmill in people with bilateral vestibulopathy
The DizzyQuest Combined with Accelerometry: Daily Physical Activities and Limitations among Patients with Bilateral Vestibulopathy Due to DFNA9